PT1264828E - Inibidor de uroquinase - Google Patents
Inibidor de uroquinaseInfo
- Publication number
- PT1264828E PT1264828E PT02016038T PT02016038T PT1264828E PT 1264828 E PT1264828 E PT 1264828E PT 02016038 T PT02016038 T PT 02016038T PT 02016038 T PT02016038 T PT 02016038T PT 1264828 E PT1264828 E PT 1264828E
- Authority
- PT
- Portugal
- Prior art keywords
- optionally
- alkyl
- substituted
- aryl
- ring
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 10
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 abstract 6
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 abstract 6
- 125000003118 aryl group Chemical group 0.000 abstract 6
- 229960005356 urokinase Drugs 0.000 abstract 6
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 125000005842 heteroatom Chemical group 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 101100440695 Dictyostelium discoideum corB gene Proteins 0.000 abstract 2
- -1 Sulfonyl-substituted 3-amidino-phenylalanine Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 2
- 230000006806 disease prevention Effects 0.000 abstract 2
- 210000002751 lymph Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000008685 targeting Effects 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- IVWWFWFVSWOTLP-YVZVNANGSA-N (3'as,4r,7'as)-2,2,2',2'-tetramethylspiro[1,3-dioxolane-4,6'-4,7a-dihydro-3ah-[1,3]dioxolo[4,5-c]pyran]-7'-one Chemical compound C([C@@H]1OC(O[C@@H]1C1=O)(C)C)O[C@]21COC(C)(C)O2 IVWWFWFVSWOTLP-YVZVNANGSA-N 0.000 abstract 1
- DSSGKVAUNCQJTG-UHFFFAOYSA-N C(C)OC(=O)N1CCN(CC1)C(C(N)(CC1=CC(=CC=C1)C(N)=N)S(=O)(=O)C1=C(C=C(C=C1C(C)C)C(C)C)C(C)C)=O Chemical compound C(C)OC(=O)N1CCN(CC1)C(C(N)(CC1=CC(=CC=C1)C(N)=N)S(=O)(=O)C1=C(C=C(C=C1C(C)C)C(C)C)C(C)C)=O DSSGKVAUNCQJTG-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001409 amidines Chemical class 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000005553 heteroaryloxy group Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98113519 | 1998-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1264828E true PT1264828E (pt) | 2004-08-31 |
Family
ID=8232314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02016038T PT1264828E (pt) | 1998-07-20 | 1999-07-20 | Inibidor de uroquinase |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6624169B1 (pt) |
| EP (2) | EP1264828B1 (pt) |
| JP (1) | JP4603162B2 (pt) |
| AT (2) | ATE264103T1 (pt) |
| AU (1) | AU754958B2 (pt) |
| BR (1) | BR9912327B1 (pt) |
| CA (1) | CA2338073C (pt) |
| DE (2) | DE59903981D1 (pt) |
| ES (2) | ES2219607T3 (pt) |
| MX (1) | MXPA01000553A (pt) |
| PT (1) | PT1264828E (pt) |
| WO (1) | WO2000004954A2 (pt) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59806475D1 (de) * | 1998-09-18 | 2003-01-09 | Pentapharm Ag Basel | Urokinase-inhibitoren |
| DE10013715A1 (de) | 2000-03-20 | 2001-09-27 | Wilex Biotechnology Gmbh | Hochselektive Inhibitoren des Urokinase-Plasminogenaktivators |
| DE10029014A1 (de) * | 2000-06-15 | 2001-12-20 | Univ Schiller Jena | Urokinase-Hemmstoffe |
| DE50211672D1 (de) | 2001-03-21 | 2008-03-27 | Wilex Ag | Urokinase-inhibitoren |
| WO2003076391A2 (de) | 2002-03-11 | 2003-09-18 | Curacyte Ag | Hemmstoffe der urokinase, ihre herstellung und verwendung |
| DE10225876A1 (de) * | 2002-06-11 | 2003-12-24 | Wilex Ag | Guanidinophenylalaninverbindungen als Urokinase-Inhibitoren |
| DE10233632A1 (de) * | 2002-07-24 | 2004-02-05 | Wilex Ag | Formulierungen von Phenylalanin-Derivaten |
| DE10238048A1 (de) * | 2002-07-25 | 2004-02-05 | Wilex Ag | Verfahren zur Herstellung von Phenylalanin-Derivaten |
| US7247724B2 (en) * | 2002-07-25 | 2007-07-24 | Wilex Ag | Method for the production of phenylalanine derivatives |
| DE10301300B4 (de) * | 2003-01-15 | 2009-07-16 | Curacyte Chemistry Gmbh | Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein |
| DE10322191B4 (de) * | 2003-05-16 | 2014-02-27 | The Medicines Company (Leipzig) Gmbh | N-sulfonylierte Aminosäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE10323898A1 (de) | 2003-05-26 | 2004-12-23 | Wilex Ag | Hydroxyamidin- und Hydroxyguanidin-Verbindungen als Urokinase-Hemmstoffe |
| DE10342108A1 (de) * | 2003-09-11 | 2005-04-14 | Curacyte Chemistry Gmbh | Basisch-substituierte Benzylaminanaloga als Inhibitoren des Gerinnungsfaktors Xa, ihre Herstellung und Verwendung |
| EP1637529A1 (en) * | 2004-09-20 | 2006-03-22 | 4Sc Ag | Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof |
| DE102004045720A1 (de) * | 2004-09-21 | 2006-03-23 | Wilex Ag | Stabile Dosierungsform von Phenylalanin-Derivaten |
| US8093258B2 (en) | 2005-06-24 | 2012-01-10 | Wilex Ag | Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases |
| DE102006050672A1 (de) | 2006-10-24 | 2008-04-30 | Curacyte Discovery Gmbh | Hemmstoffe des Plasmins und des Plasmakallikreins |
| EP2577291A4 (en) * | 2010-05-26 | 2014-11-26 | Expression Pathology Inc | SELECTIVE REACTION MONITORING OF TYPE-1 PROTEIN INHIBITOR OF PLASMINOGEN ACTIVATOR / UROKINASE PLASMINOGEN ACTIVATORY PROTEIN |
| ES2483802T3 (es) | 2010-07-07 | 2014-08-07 | The Medicines Company (Leipzig) Gmbh | Inhibidores de serina proteasa |
| JP6755881B2 (ja) | 2015-03-30 | 2020-09-16 | サニーブルック リサーチ インスティテュート | がんを処置するための方法 |
| CN115557879B (zh) * | 2015-09-24 | 2024-02-20 | 株式会社Lg化学 | 化合物和包含其的有机电子器件 |
| CN108136207A (zh) * | 2015-10-06 | 2018-06-08 | 红山生物医药有限公司 | 用于治疗癌症的联合疗法 |
| KR20220151613A (ko) | 2020-03-10 | 2022-11-15 | 레드힐 바이오파마 엘티디 | 코로나바이러스 감염의 치료 |
| US11471448B2 (en) | 2020-12-15 | 2022-10-18 | Redhill Biopharma Ltd. | Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU541738B2 (en) * | 1979-09-20 | 1985-01-17 | Nippon Chemiphar Co. Ltd. | Cyclohexane carboxylic acid derivatives |
| DE3577700D1 (de) * | 1984-11-30 | 1990-06-21 | Shosuke Okamoto | Lysinderivat und proteinase-inhibitor. |
| JPH05503300A (ja) * | 1990-11-15 | 1993-06-03 | ペンタファルム アクチェンゲゼルシャフト | メタ置換フェニルアラニン誘導体 |
| DE59410179D1 (de) * | 1993-02-10 | 2002-10-10 | Pentapharm Ag Basel | Piperazide von substituierten phenylalanin-derivativen als thrombin inhibitoren |
| US5550213A (en) | 1993-12-27 | 1996-08-27 | Rutgers, The State University Of New Jersey | Inhibitors of urokinase plasminogen activator |
| AU3107795A (en) * | 1994-08-09 | 1996-03-07 | Pentapharm Ag | Inhibitors of the benzamidine type |
| DE9418185U1 (de) * | 1994-11-12 | 1995-02-23 | Wolf Gmbh Richard | Behälter für medizinische Instrumente |
| CH689611A5 (de) * | 1995-03-01 | 1999-07-15 | Pentapharm Ag | Urokinase-Inhibitoren. |
| DE59806475D1 (de) * | 1998-09-18 | 2003-01-09 | Pentapharm Ag Basel | Urokinase-inhibitoren |
-
1999
- 1999-07-20 WO PCT/EP1999/005145 patent/WO2000004954A2/de active IP Right Grant
- 1999-07-20 DE DE59903981T patent/DE59903981D1/de not_active Expired - Lifetime
- 1999-07-20 AT AT02016038T patent/ATE264103T1/de active
- 1999-07-20 EP EP02016038A patent/EP1264828B1/de not_active Expired - Lifetime
- 1999-07-20 ES ES02016038T patent/ES2219607T3/es not_active Expired - Lifetime
- 1999-07-20 US US09/743,800 patent/US6624169B1/en not_active Expired - Lifetime
- 1999-07-20 DE DE59909210T patent/DE59909210D1/de not_active Expired - Lifetime
- 1999-07-20 JP JP2000560945A patent/JP4603162B2/ja not_active Expired - Lifetime
- 1999-07-20 EP EP99936570A patent/EP1098651B1/de not_active Expired - Lifetime
- 1999-07-20 MX MXPA01000553A patent/MXPA01000553A/es active IP Right Grant
- 1999-07-20 ES ES99936570T patent/ES2189455T3/es not_active Expired - Lifetime
- 1999-07-20 AT AT99936570T patent/ATE230599T1/de active
- 1999-07-20 CA CA2338073A patent/CA2338073C/en not_active Expired - Fee Related
- 1999-07-20 BR BRPI9912327-4B1A patent/BR9912327B1/pt not_active IP Right Cessation
- 1999-07-20 PT PT02016038T patent/PT1264828E/pt unknown
- 1999-07-20 AU AU51615/99A patent/AU754958B2/en not_active Ceased
-
2002
- 2002-07-26 US US10/202,850 patent/US6680320B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1098651A2 (de) | 2001-05-16 |
| WO2000004954A2 (de) | 2000-02-03 |
| MXPA01000553A (es) | 2002-04-24 |
| EP1098651B1 (de) | 2003-01-08 |
| WO2000004954A3 (de) | 2000-06-22 |
| AU754958B2 (en) | 2002-11-28 |
| ATE230599T1 (de) | 2003-01-15 |
| ES2189455T3 (es) | 2003-07-01 |
| BR9912327A (pt) | 2001-05-02 |
| AU5161599A (en) | 2000-02-14 |
| DE59909210D1 (de) | 2004-05-19 |
| US6624169B1 (en) | 2003-09-23 |
| JP4603162B2 (ja) | 2010-12-22 |
| EP1264828A1 (de) | 2002-12-11 |
| BR9912327B1 (pt) | 2013-11-12 |
| EP1264828B1 (de) | 2004-04-14 |
| ES2219607T3 (es) | 2004-12-01 |
| CA2338073C (en) | 2010-09-21 |
| ATE264103T1 (de) | 2004-04-15 |
| US6680320B2 (en) | 2004-01-20 |
| DE59903981D1 (de) | 2003-02-13 |
| US20030013723A1 (en) | 2003-01-16 |
| JP2002521348A (ja) | 2002-07-16 |
| CA2338073A1 (en) | 2000-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1264828E (pt) | Inibidor de uroquinase | |
| AU4437896A (en) | Piperidine derivatives having tachykinin antagonist activity | |
| HUT75113A (en) | 4-substituted piperidine derivatives useful as neurokinin antagonists | |
| DK436289A (da) | Cycloalkyl-substituerede glutaramidderivater, farmaceutiske praeparater indeholdende disse forbindelser, forbindelserne til medicinsk anvendelse og deres anvendelse til fremstilling af laegemidler til behandling af hypertension, hjertesvigt eller renal insufficiens | |
| DE60322359D1 (de) | Imidazopyridinderivate als kinaseinhibitoren | |
| HUP0104768A2 (hu) | 4-Amino-3-oxo-azepán proteáz inhibitorok és az ezeket tartalmazó gyógyszerkészítmények | |
| ATE319705T1 (de) | Chinolyl-propylpiperidinderivate und deren verwendung als antimikrobielle wirkstoffe | |
| YU32196A (sh) | Upotreba jedinjenja za pripremanje leka korisnog za inhibiranje migracije vaskularnih ćelija glatkog mišića | |
| NO306345B1 (no) | Piperidin-derivater med PAF antagonist-aktivitet, anvendelse derav og farmasöytisk blanding | |
| NO921831L (no) | Indolderivater, fremgangsmaate for fremstilling derav samtpreparater inneholdende et slikt derivat | |
| ATE287886T1 (de) | Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b) pyridinen als cyclin- abhängige kinase-hemmer | |
| HUP0402515A2 (hu) | Szubsztituált új N-[4-(1H-imidazol-1-il)-2-fluor-fenil]-3-(trifluor-metil)-1H-pirazol-5-karboxamidok Xa faktor inhibitorok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| DK0506434T3 (da) | Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler | |
| MX9304190A (es) | Derivados novedosos de 4-[3-benzofuranil]piperidinilo y 4-[3-benzotientil]piperidinilo. | |
| CO5280088A1 (es) | Inhibidores de proteasa | |
| MEP5608A (xx) | Nova upotreba (r) – (-)-2-[5-(4-fluorofenil)-3-piridil- metilaminometil] - hromana i njegovih fiziološko prihvatljivi h soli | |
| DE60126199D1 (de) | Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen | |
| DE60120757D1 (de) | 4-substituierte chinolone zur behandlung von autoimmunerkrankungen | |
| NO953913D0 (no) | Perhydroisoindolderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene | |
| RU2317083C2 (ru) | Применение производных n-(индолкарбонил)пиперазина | |
| ATE356805T1 (de) | Oxophenylcyclohexylpropanolaminderivate, deren herstellung und verwendung in therapeutika | |
| MX9709468A (es) | Composiciones farmaceuticas para minimizar la perdida osea. | |
| DE69525548D1 (de) | Substituierte 6-h-1,3,4,-thiadiazin-2-amine, deren verwendung als anaesthetisierende, cardiovaskulare und hypometabolische mittel, und eine sie enthaltende pharmazeutische zubereitung | |
| HUP0402526A2 (hu) | Vaszkuláris betegségek gyógyítására használható hidroxilaminszármazékok, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| TH47890A3 (th) | สารยับยั้งเซรีนโปรทีเอส |